Home / Market News / $DHR

$DHR news and market catalysts

The 13 most recent market catalysts affecting $DHR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

13 catalysts 3 high impact 4 bullish 6 bearish Life Sciences & Diagnostics
Aug 14, 2026 Corporate Catalyst Neutral Impact 65
Tiger Global Management Takes New Stake In Danaher Corp With 456,000 Shares.
This headline indicates a significant institutional investor, Tiger Global Management, has initiated a new position in Danaher Corp. This can be seen as a positive signal for Danah…
Aug 3, 2026 Corporate Catalyst Bullish Impact 75
Danaher shares are trading higher after the company announced it appointed Julie Sawyer Montgomery as President and CEO.
The appointment of a new President and CEO for a company of Danaher's size and market capitalization is a significant corporate catalyst. Investors often react positively to new le…
Aug 3, 2026 Corporate Catalyst Neutral Impact 75
Danaher Appoints Julie Sawyer Montgomery As President, CEO, Effective Oct. 1, Succeeding Rainer Blair
Danaher Corporation has announced a planned CEO transition, with Julie Sawyer Montgomery taking over from Rainer Blair on October 1, 2026. This is a significant leadership change f…
Jul 24, 2026 Corporate Catalyst Bearish Impact 75
Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
Billionaire investor Daniel Loeb's decision to significantly cut his stake in Danaher and fully exit Thermo Fisher Scientific in Q1 2026 indicates a bearish outlook on the Life Sci…
Jul 22, 2026 Market Technicals Bearish Impact 65
Stock Of The Day: Is The Danaher Selloff Over?
Danaher (DHR) experienced a significant stock price drop of over 10% yesterday due to a weak earnings report, accompanied by unusually high trading volume. This filing interprets t…
Jul 22, 2026 Market Technicals Bearish Impact 55
TD Cowen Maintains Buy on Danaher, Lowers Price Target to $236
This filing indicates that TD Cowen's analyst Dan Brennan has maintained a 'Buy' rating on Danaher (DHR), signaling continued confidence in the company's long-term prospects. Howev…
Jul 22, 2026 Corporate Catalyst Bullish Impact 55
RBC Capital Maintains Outperform on Danaher, Raises Price Target to $215
RBC Capital analyst Dan Leonard maintained an 'Outperform' rating on Danaher (DHR) and raised the price target from $200 to $215. This action signals a continued bullish sentiment …
Jul 21, 2026 Corporate Catalyst Bearish Impact 95
Why Danaher Stock Just Tanked 14%
Danaher's stock experienced a sharp decline because the company lowered its fiscal 2026 core revenue growth forecast from 3-6% to 3-4% and trimmed its Bioprocessing business growth…
Jul 21, 2026 Corporate Catalyst Neutral Impact 85
Transcript: Danaher Q2 2026 Earnings Conference Call
Danaher's Q2 2026 earnings call transcript reveals a robust performance, exceeding expectations in revenue, earnings, and cash flow. The company's decision to raise its full-year a…
Jul 21, 2026 Corporate Catalyst Bearish Impact 92
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Danaher (DHR) reported Q2 adjusted EPS of $1.94, beating estimates of $1.83, and sales of $6.265 billion, topping estimates of $6.102 billion. Despite these strong results, the sto…
Jul 21, 2026 Corporate Catalyst Bearish Impact 75
Danaher shares are trading lower. The company reported Q2 financial results.
This headline signifies a direct corporate catalyst, as Danaher's Q2 financial results are driving its stock performance. The 'trading lower' indicates that the results likely disa…
Jul 21, 2026 Corporate Catalyst Bullish Impact 75
Danaher Sees Q3 Non-GAAP Core Revenue To Increase In 2.0% To 3.0% Range YoY, And FY26 Non-GAAP Core Revenue To Increase In 3.0% To 4.0% Range YoY
Danaher's guidance for non-GAAP core revenue growth, particularly the multi-year FY26 outlook, provides a positive signal for the company's long-term trajectory. While the growth r…
Jul 21, 2026 Corporate Catalyst Bullish Impact 75
Danaher Raises FY2026 Adj EPS Guidance from $8.35-$8.55 to $8.45-$8.60 vs $8.45 Est
Danaher (DHR) has raised its adjusted EPS guidance for fiscal year 2026, indicating a more optimistic outlook for its future financial performance. This upward revision, albeit mod…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.